MedTrace Logo

Blood Sugar Take Care and Glucose Metabolism

NCT01554020 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-03-12

No results posted yet for this study

Summary

This prospective international clinical trial is a two-arm, double-blind, randomized, placebo-controlled, parallel-group, multicenter study. 112 prediabetic subjects will be randomized to Blood Sugar Take Care or placebo. Randomization will be stratified by gender. The intervention period is 12 weeks. The primary outcome is fasting glucose levels.

Conditions

Interventions

DIETARY_SUPPLEMENT

Blood Sugar Take Care

One 1200 mg soft gel capsule administered 3X/day for duration of study

DIETARY_SUPPLEMENT

Placebo

One 1200 mg soft-gel capsule administered 3X/day for duration of study

Sponsors & Collaborators

  • Sprim Advanced Life Sciences

    collaborator OTHER

  • NewChapter, Inc.

    lead INDUSTRY

Principal Investigators

  • Larry Miller, PhD · Sprim Advanced Life Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-10-31
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01554020 on ClinicalTrials.gov